Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Christophe

Showing results (131-140 of 149) with videos related to

Pageof 15
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|March 10, 2018
Kinesin-1 Is a New Actor Involved in Platelet Secretion and Thrombus StabilityFrédéric Adam, Alexandre Kauskot, Mathieu Kurowska, et al.
Haematologica|April 3, 2025
Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic miceThibaud Sefiane, Geneviève McCluskey, Marie Clavel, et al.
Blood|September 22, 2025
Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibodyVincent Muczynski, Olivier D Christophe, Lewis Tanner, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.
Blood|August 25, 2001
Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia BO D Christophe, P J Lenting, G Cherel, et al.
Blood Advances|June 22, 2018
Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B plateletsCaterina Casari, David S Paul, Sophie Susen, et al.
Scientific Reports|May 24, 2016
A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammationFrédéric Adam, Caterina Casari, Nicolas Prévost, et al.
EMBO Molecular Medicine|March 12, 2020
Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitorsElena Barbon, Gabriel Ayme, Amel Mohamadi, et al.
Scientific Reports|November 29, 2016
Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activityMarion Pepin, Soraya Mezouar, Julie Pegon, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2022
Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein SJosepha C Sedzro, Frédéric Adam, Claire Auditeau, et al.
Pageof 15

Showing results (131-140 of 149) with videos related to

Sort By:
Pageof 15
Arteriosclerosis, Thrombosis, and Vascular Biology|March 10, 2018
Kinesin-1 Is a New Actor Involved in Platelet Secretion and Thrombus StabilityFrédéric Adam, Alexandre Kauskot, Mathieu Kurowska, et al.
Haematologica|April 3, 2025
Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic miceThibaud Sefiane, Geneviève McCluskey, Marie Clavel, et al.
Blood|September 22, 2025
Alternative AAV gene therapy for hemophilia A using expression of Bi8, a novel single-chain FVIII-mimetic antibodyVincent Muczynski, Olivier D Christophe, Lewis Tanner, et al.
Journal of Thrombosis and Haemostasis : JTH|July 20, 2023
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumabMelissa Bou-Jaoudeh, Angelina Mimoun, Sandrine Delignat, et al.
Blood|August 25, 2001
Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia BO D Christophe, P J Lenting, G Cherel, et al.
Blood Advances|June 22, 2018
Protein kinase C signaling dysfunction in von Willebrand disease (p.V1316M) type 2B plateletsCaterina Casari, David S Paul, Sophie Susen, et al.
Scientific Reports|May 24, 2016
A genetically-engineered von Willebrand disease type 2B mouse model displays defects in hemostasis and inflammationFrédéric Adam, Caterina Casari, Nicolas Prévost, et al.
EMBO Molecular Medicine|March 12, 2020
Single-domain antibodies targeting antithrombin reduce bleeding in hemophilic mice with or without inhibitorsElena Barbon, Gabriel Ayme, Amel Mohamadi, et al.
Scientific Reports|November 29, 2016
Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activityMarion Pepin, Soraya Mezouar, Julie Pegon, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2022
Antithrombotic potential of a single-domain antibody enhancing the activated protein C-cofactor activity of protein SJosepha C Sedzro, Frédéric Adam, Claire Auditeau, et al.
Pageof 15